Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-057879
Filing Date
2023-12-15
Accepted
2023-12-15 16:07:06
Documents
1
Period of Report
2023-12-14

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 2735
  Complete submission text file 0001140361-23-057879.txt   4150
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Issuer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ANTARES PHARMA, INC. 707 EAGLEVIEW BOULEVARD, SUITE 414 EXTON PA 19341
Business Address
Wotton Paul K (Reporting) CIK: 0001300997 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35280 | Film No.: 231490336